FDA Approves First Drug Meant to Ease Alzheimer Disease-Linked Agitation

THURSDAY, May 11, 2023 -- A medication to treat agitation in patients with Alzheimer disease now has approval from the U.S. Food and Drug Administration.
The FDA gave supplemental approval for Rexulti (brexpiprazole) oral tablets on Thursday....